The Hybritech Alumni: Where Are They Now?
Luke Timmerman3/12/10Follow @ldtimmerman
[Updated: 6:45 pm, 2/23/11] Plenty of ink has been devoted over the years to how San Diego’s biotech family tree can be traced back to Hybritech. The company was born in biotech’s halcyon days in the ’70s, and it quickly became the magnet for young scientific and business talent in San Diego. After Eli Lilly bought the place for more than $400 million in 1986, many of the young turks went on to plant seeds at new ventures all around San Diego and other biotech hubs around the world.
That story has been told well over the years, including this piece from 2003, and another in 2008 from the San Diego Union-Tribune. So instead of focusing on the well-known characters who made it happen—Ivor Royston, Howard Birndorf, Ted Greene and others—I wondered what I might find if I used modern social networking tools to dig deeper and assemble an updated directory of where Hybritech alumni are today, encompassing bigshots and rank-and-file. Getting to know the history also seemed like a good idea as I prepare to host the big event Xconomy is organizing on the 20-year outlook for San Diego life sciences on March 31.
The methods here, I must say, are pretty basic. I sought to include anybody who worked at Hybritech at some point. I looked around in the archives of other publications like the Union-Tribune, and The Scientist. I cited biographies from Forbes.com. I made heavy use of employment histories people have posted on LinkedIn. And of course, I’m citing some of my own original reporting from Xconomy. It should be noted that I can’t guarantee that all the information is up to date, especially the user-generated content from LinkedIn. The list has 196 names at last count.
Now’s where I hope you can step in to help. If you see anything that’s out of date, or incorrect, please let me know and I’ll fix it. Over time, I hope this story can become a richer and more valuable resource for Hybritech alumni to connect and re-connect.
With that, here’s the list I’ve put together in alphabetical order, with the most updated titles and affiliations I found online. If you have any questions, comments, or new information, please send me a note at ltimmerman@xconomy.com or editors@xconomy.com.
Barbara Adams (McCampbell), retired, formerly director of human resources [Added: 2:05 pm, 6/4/10]
Tom Adams, chief technology officer, Iris International
Clarence Ahlem, vice president, Harbor Biosciences (formerly Hollis-Eden Pharmaceuticals) [Added: 10:10 am, 3/12/10]
Roger Alsop, lead scientist, Prozyme
Tony Alvarez, biotechnology/medical device supply chain professional
Kim Aposporos, chemistry supervisor, Alvarado Hospital Clinical Laboratory [Added: 7:40 am, 3/15/10]
Glenn Armstrong, Senior Manager Clinical Affairs, Siemens Healthcare Diagnostics [Added: 8:05 pm, 3/14/10]
Kelley Asselmann, vice president, Cast Glass Images [Added: 9:25 am, 3/15/10]
Ronald Backes, director of business development, Hitachi Chemical Diagnostics
Richard Bartholomew, retired, former former vice president of clinical R&D at Immune Response Corp./Orchestra Therapeutics [Updated: 7 pm, 3/18/10]
Thomas Battersby, senior manager, Siemens Healthcare [Added: 10:10 am, 3/12/10]
Gina Battiste, urology marketing DTC, Astellas Pharma
Russ Bell, president, Beckman Coulter Foundation [Added: 4:20 pm, 3/14/10]
Marie Berry, director, strategic sourcing, Amylin Pharmaceuticals [Added: 2:45 pm, 3/15/10]
Charlie Birdwell, reagent manufacturing manager, Accumetrics
Howard Birndorf, board member, Adamis Pharmaceuticals
Avril Bland, contractor, Pharmaceutical Services Corp.
Kim Blickenstaff, president and CEO, Tandem Diabetes Care
Debra Bowes, founder and president, Chevy Chase BioPartners
Thomas Braden, global vice president, operations, eBioscience [Added, 5:52 pm, 3/14/10]
Shelly Brandell, marketing communications manager, Hewlett-Packard [Added: 7 pm, 3/18/10]
Teresa Brandt, regulatory affairs, Isis Pharmaceuticals
Julia Brown, principal, ForestView Advisors
Robert Buchs, managing partner, Buchs & Associates
Ken Buechler, board member, Sotera Wireless [Added: 1:15 pm, 3/12/10]
Carl Burke, senior manager of talent acquisition, Abbott Vascular Devices
Karen Gray Burnett, research associate professor, biology, College of Charleston [Added 2 pm, 3/14/10]
France Calvin, quality systems and quality training manager, Abbott Laboratories
Donna Cancel, human resources consultant, principal, DJC Consulting [Added: 9:25 am, 3/15/10]
Joseph Carangelo, Entrepreneur-in-Residence, UCSD Connect Springboard Program
Dennis Carlo, president and CEO, Adamis Pharmaceuticals
Robin Cary, senior manager of materials, Illumina [Added: 4:25 pm, 3/14/10]
Michael Chiapetta, technology executive in predictive analytics [Added: 3:40 pm, 7/7/10]
Angela Chit, senior associate, Catalent Pharma Solutions
Therese Conlin, senior scientist, Amylin Pharmaceuticals [Added: 9:25 am, 3/15/10]
Cathleen Courson, planner, Biosite [Added: 8:12 am, 3/15/10]
Bill Crean, owner, Crean & Everett Executive Search
Dale Damron, finance director, Spokane County United Way [Added: 6:45 pm, 2/23/11]
Claude Darte, manager, clinical research, Beckman Coulter [Added: 4:25 am, 3/16/10]
Gary David, biotechnology professional
Mark Densel, senior director of project management, Ardea Biosciences
Ken Derry, manager of inbound transportation, PETCO Animal Supplies
Maria DeSantis, associate director and business partner, human resources, Prometheus Laboratories
Mike Donatelli, president, cGXP Consultants
Marc Dubucq, Senior Manager Scientific Affairs Europe, Gen-Probe [Added: 3:18 pm, 3/14/10]
Ronald Dudek, director of market development, Silicon Kinetics
John Duddy, vice president at Applied Biosystems unit, Life Technologies
Patti Duffy, customer service/sales operations professional
Kathy Eure, senior director of global planning, performance and outsourcing, Baxter Healthcare
Mark Falkowski, management consultant, president and CEO Direct Medical Systems
Barbara Ferris, quality specialist, SenDx Medical
Mark Fineman, executive director of clinical pharmacology, Amylin Pharmaceuticals
Judith Finlay, technical director, The Binding Site [Added: 8:05 pm, 3/14/10]
Debra Fountaine, manufacturing quality scientist, Beckman Coulter [Added: 2:45 pm, 3/15/10]
John Frazer, scientist, Arena Pharmaceuticals [Added: 7 pm, 3/18/10]
Chet French, manager of site training, MedImmune
Judy French, manager of research operations/study management/contracts management
James Frincke, CEO, Harbor Biosciences (formerly Hollis-Eden Pharmaceuticals) [Added 10:10 am, 3/12/10]
Wendy Gaal, chief executive brewmistress, Knitters Brewing Company
Denise Garcia, director of records management solutions, WaveFront Clinical Management Services
Cam Garner, chairman of the board, Cadence Pharmaceuticals
Carlton Gasior, HTS specialist, Sanford-Burnham Medical Research Institute
Pramod Gaur, vice president TeleHealth, UnitedHealth Group
Janet Gladwin, owner, “Double You” Pet-Sitters [Added: 7:45 pm, 3/22/10]
Dee Gordon, retired, previously director of marketing, Biosite Diagnostics [Added: 3:15 pm, 3/23/10]
Sherrie Green, promotional communication specialist, Prometheus Laboratories [Added: 8:22 am, 3/15/10]
Howard “Ted” Greene, board member, Satiogen Pharmaceuticals, Tandem Diabetes Care, and CoDa Therapeutics [Updated: 7 pm, 3/18/10]
Donald Grimm, director, Hamilton BioVentures
David Hale, chairman and CEO, Hale Biopharma Ventures, chairman of Santarus, Somaxon Pharmaceuticals, and Micromet
Keith Hall, senior director, quality control & assay development, Vical [Added: 2:45 pm, 3/15/10]
Craig Halverson, principal, Halverson Biopharmaceutical Consulting
Harold Handley, principal, HHHandley Biotechnology Consulting
Tom Hastings, facilities manager, Sapphire Energy
Rachel Hernandez, Team Leader, Project Manager, Coach, Mentor
Susan Hochschwender, pharmaceutical consultant
Dee Hoffman, executive director, National Credit Restoration Alliance
Teresa Howard, senior human resources consulting, TC Howard Consulting
Bruce Huebner, managing partner, LynxCom Partners
David Huelin, manufacturing engineer,General Atomics [Added: 7:40 am, 3/15/10]
Sandy (Lindemuth) Hughes, national accounts director, Inverness Medical Innovations [Added: 3:55 pm, 3/14/10]
Bob Hussa, biotechnology consultant
Mike Jennings, facilities manager, Jones Lang LaSalle [Added: 9:40 am, 3/15/10]
Robin Jimenez, biotechnology professional
Camille Johnson, marketing manager, Inverness Medical Innovations [Added: 7:45 pm, 3/22/10]
Mike Johnson, director, product development, Mercia Pharma [Added: 7 pm, 3/18/10]
Sherry (Ahmadi) Johnson, research assistant II, The Scripps Research Institute [Added: 7 pm, 3/18/10]
David Kabakoff, executive-in-residence, Sofinnova Ventures
AnneMarie Kaiser, partner, Knobbe Martens
Patrick Keivens, associate director of quality assurance and compliance, Isis Pharmaceuticals
Mike Kendall, retired [Added: 7 pm, 3/18/10]
Karen Klause, business advisor and board director, Ridge Diagnostics [Added: 2 pm, 3/14/10]
Joelle Kord, senior drug discovery specialist, Life Technologies
Michael Kulwiec, principal, Michael Kulwiec Design Lab
Abhay Kumar, senior manager of corporate development, Life Technologies
Ed Kusnierz, manager of QA/QC, Orexigen Therapeutics
Tina Kuus, managing scientific director, The Binding Site [Added: 7 pm, 3/18/10]
Claude Lalou, molecular imaging modality manager, GE Healthcare
Paul Lambotte, business development executive
Rene Lampe, senior manager of formulations, Synbiotics [Added: 8:12 am, 3/15/10]
Randal Lane, senior director, pharmaceutical development, and San Diego assistant managing director, Cato Research [Added: 9:25 am, 3/15/10]
Robert Lannom, validation manager, Beckman Coulter [Added: 2:45 pm, 3/15/10]
Judy Lash, materials management, retired [Added: 10 pm, 3/15/10]
Steve Laub, quality control scientist, Beckman-Coulter [Added: 7:40 am, 3/15/10]
Paul Leitch, shipping/facilities manager, The Binding Site [Added: 9:25 am, 3/15/10]
Jyh-Feei Lin, biotechnology professional [Added: 7 pm, 3/18/10]
Steven Lowe, regional area manager, Allergan
Rick Ludwig, author and scientist
Andrea Lynn, marketing director, PacificGMP [Added: 6:02 am, 3/15/10]
Michael Macau, area director, west, Roche Diagnostics [Added: 4:15 pm, 3/14/10]
Jose Mallabo, director of international corporate communications, LinkedIn
Chris Manzuk, project engineer, Inverness Medical Innovations [Added: 2:45 pm, 3/15/10]
Gayle Mayfield-Venieris, owner/attorney, Mayfield & Associates [Added: 2:45 pm, 3/15/10]
Richard McEachern, director of engineering, Azure Institute [Added: 2:45 pm, 3/15/10]
Stephanie McEvoy, retired [Added: 7 pm, 3/18/10]
Susan Meineke, senior director of human resources, Metabasis Therapeutics
Bruce Merchant, owner, Merchant-Taylor International [Added: 3:50 pm, 3/14/10]
Damon Meyer, principal scientist, process chemistry, Seattle Genetics [Added: 3 pm, 3/14/10]
Susan Miller, biochemist, Dow Chemical
Carl Mongiovi, vice president, Phamatech [Added: 2:45 pm, 3/15/10]
Deborah Mongiovi, associate director, clinical development, Halozyme Therapeutics [Added: 7 pm, 3/18/10]
Margaret Moore, principal investigator, Imdaptive
Kevin Nakamura, director of research, Astute Medical
Gina Nelson, pharmaceutical market research consultant [Added: 3:10 pm, 3/14/10]
Donna Nichols, investor relations professional
Randy Nielsen, manager of QC and stability, Catalent Pharma Solutions
Tina Nova, co-founder, president and CEO, Genoptix Medical
Susan Nowakowski, president and CEO, AMN Healthcare Services
Janice Ohta, board member, Caltech Associates
Karl Olsen, chief financial officer and head of operations, GNF
Paul O’Shaughnessy, senior marketing manager, off-portal content, AT&T Mobility
Cole Owen, president, Owen & Associates [Added: 1:15 pm 3/12/10]
Bob Parson, vice president of global clinical and regulatory affairs, Inverness Medical Innovations
Jim Patterson, Owner/Partner, System1Search [Added: 8:05 pm, 3/14/10]
Philip Paul, Chairman, Paul Capital Partners [Added: 8:30 pm, 3/14/10]
Melinda (Hackett) Paulis, marketing consultant [Added: 7 pm, 3/18/10]
Greg Payne, director, BD
Liz Perkins, associate director of marketing communications, Prometheus Laboratories
Caryn Peterson, partner, DSC Associates
Leigh Pierce, president and CSO, PacificGMP
Ken Poggenburg, independent pharmaceuticals professional
Norbert Purro, director of pharmaceutical sciences, Pharmacyclics [Added: 3:40 pm, 7/7/10]
Noorul Rahman, consultant at TRL Enterprises
Pamela Resch, director, regulatory affairs, Vical [Added: 9:25 am, 3/15/10]
Lyle Rice, vice president of development, LEAP Biosciences [Added: 10 am, 3/23/10]
Don Rindell, executive director, Amylin Pharmaceuticals
Mark Robertson, owner, Mark Robertson Puppets
Steve Roman, senior scientist, Life Technologies
Paulette Roper, senior manager of eSolutions, Allergan
Paul Rosinack, president & CEO, Qualigen [Added: 9:25 am, 3/15/10]
Ivor Royston, managing member, Forward Ventures
Kale Ruby, vice president of CMC and Quality Assurance, MediciNova
Jane Ryskamp, vice president, global supply chain, Amylin Pharmaceuticals [Added: 7 pm, 3/18/10]
H.F. “Butch” Sanders, senior operations/product management executive
Mark Sarno, president, Vision Biotechnology Consulting [Added: 8:05 pm, 3/14/10]
Charles Schaus, project manager, Eurogentec
Lou Schioppi, senior business development manager, Patheon Pharmaceuticals
Scott Schubert, senior technical operations scientist, Beckman Coulter [Added: 7 pm, 3/18/10]
Blair Shamel, president, The Shamel Group
Mark Shannon, president, Quadrants Scientific
Hal Siegel, vice president and chief scientific officer, ImmuneRegen Biosciences [Added: 4:08 pm, 3/14/10]
Linda Simmons, senior business analyst, global supply chain, Amylin Pharmaceuticals
Paul Skoczelas, senior manager, trade relations, Prometheus Laboratories [Added: 9:25 am, 3/15/10]
Diane Smith, owner, All Track [Added: 2:50 pm, 3/15/10]
William Soo Hoo, vice president, Jaden Bioscience
Grace Soriano, biotechnology professional
Paula Southwick, group manager of clinical research, Beckman Coulter
Sharron Starkey, director of QA/RA, Accumetrics
Barb Stevens, owner, Stevens and Associates [Added: 2:30 pm, 3/14/10]
Richard Stewart, owner, Stewart ComGraph [Added: 8:05 pm, 3/14/10]
Susan Strobel, principal writer, SciComm
Dean Tallam, president, Syndeo [Added: 3:40 pm, 7/7/10]
Daria Tansey, biotechnology professional, retired [Added: 9:25 am, 3/15/10]
Ron Taylor, board member, ResMed, Watson Pharmaceuticals, 3E, EMN8, Safelife [Added: 5:30 pm, 3/14/10]
Bruce Tedeschi, CEO, Digibroker [Added: 8:05 pm, 3/14/10]
Lynn Terhorst, consultant
Michael Ternavan, biotechnology professional
Judy Thompson, buyer II, Inova Diagnostics
Keith Timm, owner, Timm & Associates
Betty Tran, pharmaceutical consultant
Barbara Unger, director, corporate quality compliance, Amgen [Added, 2:30 pm, 3/14/10]
Michael Unger, director, project management & strategic operations, Amgen [Added: 2:45 pm, 3/15/10]
Janice (Hillesheim) Valdivia, office administrator, Forward Ventures [Added: 7 pm, 3/18/10]
Gunars Valkirs, former SVP of discovery and co-founder, Biosite. [Added: 1:15 pm 3/12/10]
Brent Vaughan, chief business officer, KineMed
Patrick Walsh, biotechnology professional
Rosemary Wareham, nurse practitioner, Minute Clinic CVS pharmacy Solana Beach [Added: 4:20 am, 3/16/10]
Jeff Watkins, CEO, aTyr Pharma
Toni Wayne, vice president of human resources, Prometheus Laboratories
Robin Weaver, consultant, Regulatory Writing Services [Added: 10 pm, 3/15/10]
Ty Webb, board member, SLA [Added: 9:30 pm, 3/23/10]
Cheryl White, corporate vice president, quality, Baxter International [Added: 8:35 pm, 3/14/10]
Karl Wiersholm, interim CFO
Mark S. Wilson, senior advisor, Rondaxe Pharma [Updated: 9:25 am, 3/15/10]
Bob Wolfert, chief scientific officer, diaDexus [Added: 6:10 am, 3/24/10]
Timothy Wollaeger, managing director, Sanderling Ventures
Kenneth Woolcott, president and founder, Six Degrees Capital
Marie Jeanne Yerna, scientific marketing manager, Beckman Coulter [Added: 4:20 am, 3/16/10]
Pingback: The Hybritech Alumni: Where Are They Now? « NCTimes.com Blogs